|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
18 April 2017 |
|
Main ID: |
ChiCTR-IPR-15006367 |
|
Date of registration:
|
2015-05-04 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Mechanism on angiotensin II influencing early recurrence of atrial fibrillation after radiofrequency ablation via LR-4/NF-kB pathway
|
|
Scientific title:
|
Mechanism on angiotensin II influencing early recurrence of atrial fibrillation after radiofrequency ablation via LR-4/NF-kB pathway |
|
Date of first enrolment:
|
2015-06-30 |
|
Target sample size:
|
olmesartan:30;control:30; |
|
Recruitment status: |
Pending |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=10920 |
|
Study type:
|
Interventional study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
Post-market
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Fang Hong
|
|
Address:
|
389 Xincun Road, Putuo district, Shanghai, China
200065
|
|
Telephone:
|
+86 21 66111529 |
|
Email:
|
de_61@163.com |
|
Affiliation:
|
|
|
|
Name:
|
Fang Hong
|
|
Address:
|
389 Xincun Road, Putuo district, Shanghai, China
200065
|
|
Telephone:
|
+86 21 66111529 |
|
Email:
|
de_61@aliyun.com |
|
Affiliation:
|
Tongji Hospital Affiliated to Tongji Medical College, Tongji University, Shanghai |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: According to the ethics rules and diagnostic criteria on 2010 ESC guidelines for the management of AF, the selection of cases underwent catheter ablation were enrolled in our study. (The patient Baseline clinical characteristics were shown in table 1). Types of AF were defined according to ESC guidelines. All human studies require institutional review board approval. They were newly enrolled in this study, and none had a history of ablation.
Exclusion criteria: Patients were excluded if they had known acute or chronic inflammatory conditions (including infectious, autoimmune, or cancerous diseases), renal disease, a history of myocardial infarction, or heart failure.
Age minimum:
60
Age maximum:
75
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
atrial fibrillation
|
|
Intervention(s)
|
|
olmesartan:olmesartan;control:Nil;
|
|
Primary Outcome(s)
|
|
TLR4, MyD88, NF-kB;
|
|
Source(s) of Monetary Support
|
|
Tongji Hospital Affiliated to Tongji Medical College, Tongji University
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|